Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Loss and Comprehensive Loss

v3.10.0.1
Consolidated Statements of Loss and Comprehensive Loss - USD ($)
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Consolidated Statements of Loss and Comprehensive Loss [Abstract]    
Sales $ 65,762,946 $ 82,322,618
Cost of sales 44,455,697 61,486,379
Gross profit 21,307,249 20,836,239
Operating expenses:    
Selling, general and administrative expenses 27,501,691 28,699,138
Impairment loss   1,617,389
Restructuring expense 363,676 2,284,541
Total operating expenses 27,865,367 32,601,068
Operating loss (6,558,118) (11,764,829)
Other income (expenses):    
Investment and other income 299,555 52,992
Loss on sale of assets (89,550) (76,870)
Interest and other expense (38,355) (71,428)
Other income (expense), net 171,650 (95,306)
Loss from operations before income taxes (6,386,468) (11,860,135)
Income tax expense (benefit) 405,267 (34,503)
Net loss (6,791,735) (11,825,632)
Other comprehensive (loss) income, net of tax:    
Unrealized gains/(losses) on available-for-sale securities 1,061 (4,566)
Foreign currency translation adjustment (138,975) 77,848
Total other comprehensive (loss) income (137,914) 73,282
Comprehensive loss $ (6,929,649) $ (11,752,350)
Basic net loss per share: $ (0.75) $ (1.32)
Diluted net loss per share: $ (0.75) $ (1.32)
Weighted Average Basic Shares Outstanding 9,108,777 8,942,523
Weighted Average Dilutive Shares Outstanding 9,108,777 8,942,523